226 related articles for article (PubMed ID: 16617455)
1. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
[TBL] [Abstract][Full Text] [Related]
2. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.
Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H
Thorax; 2005 Apr; 60(4):320-5. PubMed ID: 15790988
[TBL] [Abstract][Full Text] [Related]
3. Genetic modifiers of lung disease in cystic fibrosis.
Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
[TBL] [Abstract][Full Text] [Related]
4. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
[TBL] [Abstract][Full Text] [Related]
5. An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis.
Henry MT; Cave S; Rendall J; O'Connor CM; Morgan K; FitzGerald MX; Kalsheker N
Eur J Hum Genet; 2001 Apr; 9(4):273-8. PubMed ID: 11313771
[TBL] [Abstract][Full Text] [Related]
6. A cystic fibrosis mutation associated with mild lung disease.
Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
[TBL] [Abstract][Full Text] [Related]
7. Association of common haplotypes of surfactant protein A1 and A2 (SFTPA1 and SFTPA2) genes with severity of lung disease in cystic fibrosis.
Choi EH; Ehrmantraut M; Foster CB; Moss J; Chanock SJ
Pediatr Pulmonol; 2006 Mar; 41(3):255-62. PubMed ID: 16429424
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation for pulmonary function in cystic fibrosis.
de Gracia J; Mata F; Alvarez A; Casals T; Gatner S; Vendrell M; de la Rosa D; Guarner L; Hermosilla E
Thorax; 2005 Jul; 60(7):558-63. PubMed ID: 15994263
[TBL] [Abstract][Full Text] [Related]
10. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
[TBL] [Abstract][Full Text] [Related]
13. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A
Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219
[TBL] [Abstract][Full Text] [Related]
14. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease.
Frangolias DD; Ruan J; Wilcox PJ; Davidson AG; Wong LT; Berthiaume Y; Hennessey R; Freitag A; Pedder L; Corey M; Sweezey N; Zielenski J; Tullis E; Sandford AJ
Am J Respir Cell Mol Biol; 2003 Sep; 29(3 Pt 1):390-6. PubMed ID: 12689922
[TBL] [Abstract][Full Text] [Related]
15. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
Geborek A; Hjelte L
J Cyst Fibros; 2011 May; 10(3):187-92. PubMed ID: 21354377
[TBL] [Abstract][Full Text] [Related]
16. Disease modifying genes in cystic fibrosis.
Slieker MG; Sanders EA; Rijkers GT; Ruven HJ; van der Ent CK
J Cyst Fibros; 2005 Aug; 4 Suppl 2():7-13. PubMed ID: 15996905
[TBL] [Abstract][Full Text] [Related]
17. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
18. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
19. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
20. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
